Imagion Biosystems Ltd (IBX) - Cash Flow Conversion Efficiency

Latest as of December 2025: 1.048x

Based on the latest financial reports, Imagion Biosystems Ltd (IBX) has a cash flow conversion efficiency ratio of 1.048x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-2.27 Million ≈ $-1.60 Million USD) by net assets (AU$-2.16 Million ≈ $-1.53 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See IBX equity financing ratio to measure how much of total assets are equity-financed.

Imagion Biosystems Ltd - Cash Flow Conversion Efficiency Trend (2014–2025)

This chart illustrates how Imagion Biosystems Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Imagion Biosystems Ltd (IBX) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.

Imagion Biosystems Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Imagion Biosystems Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Click Holdings Limited NASDAQ:CLIK	-0.002x
Sulliden Minerals SA TO:SMC	0.090x
Zeb Nickel Corp V:ZBNI	0.003x
TAIZHOU WATER GRP. H YC 1 F:GX5	N/A
FATHOM NICKEL INC. F:6Q5	-0.001x
Lion Energy Ltd AU:LIO	-0.111x
Danasupra Erapacific Tbk JK:DEFI	-0.095x
Rare Earth Magnesium Technology Group Holdings Limited STU:GPS	0.016x

Annual Cash Flow Conversion Efficiency for Imagion Biosystems Ltd (2014–2025)

The table below shows the annual cash flow conversion efficiency of Imagion Biosystems Ltd from 2014 to 2025. For the full company profile with market capitalisation and key ratios, see Imagion Biosystems Ltd (IBX) total market value.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	AU$-2.16 Million ≈ $-1.53 Million	AU$-4.04 Million ≈ $-2.86 Million	1.870x	+236.07%
2024-12-31	AU$-2.28 Million ≈ $-1.62 Million	AU$-1.27 Million ≈ $-899.04K	0.557x	-74.65%
2023-12-31	AU$-3.79 Million ≈ $-2.68 Million	AU$-8.32 Million ≈ $-5.88 Million	2.195x	+227.18%
2022-12-31	AU$4.68 Million ≈ $3.31 Million	AU$-8.07 Million ≈ $-5.71 Million	-1.726x	-353.14%
2021-12-31	AU$13.31 Million ≈ $9.41 Million	AU$-5.07 Million ≈ $-3.59 Million	-0.381x	-6.41%
2020-12-31	AU$12.91 Million ≈ $9.14 Million	AU$-4.62 Million ≈ $-3.27 Million	-0.358x	+74.55%
2019-12-31	AU$2.97 Million ≈ $2.10 Million	AU$-4.18 Million ≈ $-2.96 Million	-1.406x	+33.10%
2018-12-31	AU$3.87 Million ≈ $2.74 Million	AU$-8.13 Million ≈ $-5.76 Million	-2.102x	-109.47%
2017-12-31	AU$6.95 Million ≈ $4.92 Million	AU$-6.98 Million ≈ $-4.94 Million	-1.004x	-4289.57%
2016-12-31	AU$11.69 Million ≈ $8.27 Million	AU$-267.26K ≈ $-189.10K	-0.023x	-104.80%
2015-12-31	AU$-8.86 Million ≈ $-6.27 Million	AU$-4.22 Million ≈ $-2.99 Million	0.477x	-22.14%
2014-12-31	AU$-3.97 Million ≈ $-2.81 Million	AU$-2.43 Million ≈ $-1.72 Million	0.612x	--

About Imagion Biosystems Ltd

AU:IBX Australia Diagnostics & Research

Market Cap

$4.17 Million

AU$5.89 Million AUD

Market Cap Rank

#28888 Global

#1574 in Australia

Share Price

AU$0.01

Change (1 day)

-7.69%

52-Week Range

AU$0.01 - AU$0.05

All Time High

AU$8.60